Table 2.
Kidney Dysfunction | Kidney Damage | |||
---|---|---|---|---|
Normal eGFR ≥ 60 mL/min/1.73 m2 | Decreased eGFR < 60 mL/min/1.73 m2 | Elevated UACR ≥ 17 mg/g | Normal UACR < 17 mg/g | |
Testosterone (nmol/L) | ||||
Crude | 19.3 ± 0.3 | 15.1 ± 0.7* | 16.7 ± 0.6** | 19.5 ± 0.3 |
Age-Adjusted | 19.1 ± 0.2 | 19.5 ± 1.1 | 18.5 ± 0.7 | 19.2 ± 0.3 |
Multivariable Adjusted† | 18.0 ± 0.3 | 18.5 ± 0.8 | 17.3 ± 0.7 | 18.0 ± 0.3 |
Estradiol (pmol/L) | ||||
Crude | 137.7 ± 2.7 | 135.9 ± 4.9 | 134.7 ± 6.7 | 137.9 ± 2.5 |
Age-Adjusted | 137.3 ± 2.7 | 145.7 ± 5.7 | 138.6 ± 7.4 | 137.4 ± 2.4 |
Multivariable Adjusted† | 124.7 ± 3.3 | 137.3 ± 5.8* | 125.8 ± 8.5 | 125.2 ± 3.0 |
SHBG (nmol/L) | ||||
Crude | 38.0 ± 0.8 | 48.9 ± 3.0** | 42.9 ± 2.2* | 37.9 ± 0.7 |
Age-Adjusted | 38.4 ± 0.8 | 36.9 ± 2.9 | 37.9 ± 2.1 | 38.4 ± 0.76 |
Multivariable Adjusted† | 37.8 ± 0.9 | 35.9 ± 2.7 | 37.8 ± 2.3 | 37.8 ± 0.9 |
Molar Estradiol:Testosterone (x 103) | ||||
Crude | 9.9 ± 1.3 | 15.0 ± 3.8 | 15.6 ± 5.2 | 9.5 ± 1.2 |
Age-Adjusted | 10.1 ± 1.3 | 10.6 ± 3.8 | 13.9 ± 5.4 | 9.7 ± 1.3 |
Multivariable Adjusted† | 10.8 ± 2.3 | 11.9 ± 3.6 | 15.7 ± 6.5 | 10.3 ± 2.1 |
Estimated Free Testosterone (nmol/L) | ||||
Crude | 0.39 ± 0.006 | 0.26 ± 0.007** | 0.32 ± 0.014** | 0.39 ± 0.007 |
Age-Adjusted | 0.38 ± 0.004 | 0.40 ± 0.015 | 0.39 ± 0.014 | 0.38 ± 0.004 |
Multivariable Adjusted† | 0.36 ± 0.004 | 0.39 ± 0.011* | 0.36 ± 0.015 | 0.36 ± 0.004 |
Estimated Free Estradiol (pmol/L) | ||||
Crude | 3.54 ± 0.08 | 3.38 ± 0.10 | 3.39 ± 0.13 | 3.55 ± 0.07 |
Age-Adjusted | 3.52 ± 0.08 | 3.81 ± 0.13 | 3.56 ± 0.16 | 3.53 ± 0.07 |
Multivariable Adjusted† | 3.17 ± 0.09 | 3.59 ± 0.14* | 3.19 ± 0.16 | 3.18 ± 0.08 |
p<0.05 compared to eGFR ≥ 60mL/min/1.73 m2
p<0.0001 compared to eGFR ≥ 60 mL/min/1.73 m2 or UACR <17 mg/g where appropriate
Adjusted for age, race, systolic and diastolic blood pressures, percent body fat, smoking status, diabetes, hypertension medication use